Bio-Techne Corp.
Income Statement
| Line Item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.22B | $1.22B | $1.16B | $1.14B | $1.11B | $931.0M | $738.7M | $714.0M |
| Biotechnology | — | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Clinical Controls | — | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Protein Platforms | — | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Protein Sciences | — | $870.2M | $830.9M | $845.7M | $832.3M | $704.6M | $555.4M | $543.2M |
| Diagnostics and Genomics | — | $0 | $0 | $0 | $274.8M | $227.7M | $184.5M | $171.7M |
| Diagnostics and Spatial Biology | — | $346.3M | $326.4M | $292.6M | $0 | $0 | $0 | $0 |
| Other | — | $4.2M | $4.2M | $0 | $0 | $0 | $0 | $0 |
| Eliminations | — | $-1.0M | $-2.4M | $-1.6M | $-1.6M | $-1.3M | $-1.2M | $-827.0K |
| Cost of Revenue | $416.0M | $429.4M | $389.3M | $366.9M | $349.1M | $298.2M | $255.5M | $240.5M |
| Gross Profit | $799.1M | $790.3M | $769.7M | $769.8M | $756.5M | $632.9M | $483.2M | $473.5M |
| Gross Margin | 65.8% | 64.8% | 66.4% | 67.7% | 68.4% | 68.0% | 65.4% | 66.3% |
| Operating Expenses | ||||||||
| Research & Development | — | — | — | — | — | — | — | — |
| SG&A Expense | $452.4M | $588.5M | $466.4M | $378.4M | $372.8M | $325.0M | $260.6M | $264.4M |
| Operating Income | $251.9M | $102.3M | $206.7M | $298.9M | $296.6M | $237.3M | $157.4M | $146.7M |
| Operating Margin | 20.7% | 8.4% | 17.8% | 26.3% | 26.8% | 25.5% | 21.3% | 20.5% |
| Interest Expense | — | — | — | $11.2M | $11.3M | $14.0M | $19.2M | $21.7M |
| Pretax Income | $240.7M | $98.5M | $185.7M | $338.7M | $301.4M | $148.2M | $276.5M | $112.0M |
| Income Tax Expense | $58.8M | $25.1M | $17.6M | $53.2M | $38.3M | $8.6M | $47.2M | $15.9M |
| Net Income | $181.9M | $73.4M | $168.1M | $285.3M | $272.1M | $140.4M | $229.3M | $96.1M |
| Net Margin | 15.0% | 6.0% | 14.5% | 25.1% | 24.6% | 15.1% | 31.0% | 13.5% |
| EPS (Basic) | $1.17 | $0.47 | $1.07 | $1.81 | $1.73 | $0.91 | $1.50 | $0.64 |
| EPS (Diluted) | $1.16 | $0.46 | $1.05 | $1.76 | $1.66 | $0.87 | $1.46 | $0.62 |
| Shares Outstanding (Basic) | 156.0M | 157.5M | 157.7M | 157.2M | 156.9M | 155.0M | 152.8M | 151.1M |
| Shares Outstanding (Diluted) | 157.0M | 159.7M | 160.8M | 161.9M | 164.1M | 161.9M | 157.6M | 155.6M |
| Dividends Per Share | $0.32 | $0.32 | $0.32 | $0.32 | $0.32 | $0.32 | $0.32 | $0.32 |